Yifan Pharmaceutical: Announcement on the proposed selection of wholly-owned subsidiaries to participate in the national centralized drug procurement (insulin special continuation)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.